Phase 3 Trial Design: The FDA agreed with Adagene’s proposed standard-of-care (SOC) control arm for the Phase 3 clinical trial and confirmed that a muzastotug monotherapy arm was also not required.

Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous ...

Amar Saurabh, a former product manager at Meta and TikTok used a custom GPT to enhance his job search. The techie ended up ...

Timothy Young is a visionary entrepreneur, executive, and investor, currently serving as CEO of Jasper AI, an AI-driven ...

Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug ...

Discover how OpenAI's Atlas browser integrates AI to assist with tasks, improve productivity, and compete with established browsers like Chrome ...

The Phase 1 clinical trial is a randomized, double-blind, placebo-controlled study evaluating single and multiple ascending doses of FT2109 in healthy adult volunteers. The trial will assess the ...

Discover how Group Captain Sanjeev Kumar Mittal transformed Narayana Nethralaya into a leading healthcare institution through strategic leadership and ethical governance.

Digital marketing is constantly changing, and it's important to keep up with the trends to stay ahead of the competition.

Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is gen ...